Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Boehringer Ingelheim
US Department of Justice
US Army
Citi
Colorcon
Dow
Julphar
Baxter

Generated: July 15, 2018

DrugPatentWatch Database Preview

HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; propranolol hydrochloride and what is the scope of hydrochlorothiazide; propranolol hydrochloride patent protection?

Hydrochlorothiazide; propranolol hydrochloride
is the generic ingredient in seven branded drugs marketed by Wyeth Ayerst, Wyeth Pharms Inc, Duramed Pharms Barr, Actavis Elizabeth, Ani Pharms Inc, Ivax Sub Teva Pharms, Mylan, Warner Chilcott, Watson Labs, and Yaopharma Co Ltd, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; propranolol hydrochloride. One supplier is listed for this compound.
Pharmacology for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 071553-001 Dec 1, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms Inc PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070705-001 Oct 1, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070301-001 Apr 18, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc INDERIDE-40/25 hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 018031-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst INDERIDE LA 120/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-002 Jul 3, 1985 ➤ Sign Up ➤ Sign Up
Wyeth Ayerst INDERIDE LA 80/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-001 Jul 3, 1985 ➤ Sign Up ➤ Sign Up
Wyeth Ayerst INDERIDE LA 160/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-003 Jul 3, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Cantor Fitzgerald
Teva
Cerilliant
Federal Trade Commission
Accenture
Harvard Business School
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.